medical education Archives

“Round Table” reality check – do new therapeutic options hold their promise?

19 September 201719 September 2017 by Hendrik Rohleder

Hendrik Rohleder

265

In addition to approval by national/international authorities, each drug or treatment has to prove its value in daily clinical practice, or what is frequently called the real world. In the long run, a medical treatment only turns out to be successful, if (a) it incorporates the needs of both physicians…

From push to pull

10 March 201717 August 2017 by Christian Guhlke

Christian Guhlke

907

Why effective multi-channel marketing is primarily a listen and learn exercise Over the last few years, the way physicians learn has dramatically changed. They access learning materials and information that helps them in their daily work ‘on the run,’ and therefore need formats that suit their requirements. This is visible…

Digitally yours

1 February 20177 June 2017 by Ingo Barmsen

Ingo Barmsen

584

How to build effective relationships in virtual space Can you imagine a life without mobile and digital access? While the proportion of everyday transactions conducted by mobile and online is increasing, it is only logical that the resource-poor healthcare sector should also ‘boldly go’ into formerly unknown territories. Statistics published…

PM360 Trailblazer Finalist 2016

1 February 201729 March 2017 by Alexandra Henschel

Alexandra Henschel

508

We are proud to have been named Finalist for the PM360 Trailblazer Awards in two categories: the Digital Solution category for the IPF Educational Portal and the HCP Initiative Category for the IPF Digital Initiative

And the winner is….

1 February 20177 June 2017 by Alexandra Henschel

Alexandra Henschel

568

Pharmaceutical Market Excellence Awards, Winner Category: "Rare Diseases and Orphan Drugs" For the IPF Digital Initiative – a combination of several customer and patient-centric education and support programmes developed by infill healthcare communication for Boehringer Ingelheim GmbH. Judges' comment: “Boehringer Ingelheim carried out detailed research into this rare…

Mastering the rare disease challenge

15 July 201629 May 2017 by Anna Hermann

Anna Hermann

477

Orphan drugs are few and far between. Long awaited by patients and physicians it should be an easy job to market them. However, diagnosis comes before treatment and with more than 6,000 rare diseases prevalent in Europe alone, it is little surprising that physicians are vague on specifics. Clinicians have…